197 related articles for article (PubMed ID: 25708222)
21. Cardiac transplantation in children with Noonan syndrome.
McCallen LM; Ameduri RK; Denfield SW; Dodd DA; Everitt MD; Johnson JN; Lee TM; Lin AE; Lohr JL; May LJ; Pierpont ME; Stevenson DA; Chatfield KC
Pediatr Transplant; 2019 Sep; 23(6):e13535. PubMed ID: 31259454
[TBL] [Abstract][Full Text] [Related]
22. Cochlear implantation and clinical features in patients with Noonan syndrome and Noonan syndrome with multiple lentigines caused by a mutation in PTPN11.
van Nierop JWI; van Trier DC; van der Burgt I; Draaisma JMT; Mylanus EAM; Snik AF; Admiraal RJC; Kunst HPM
Int J Pediatr Otorhinolaryngol; 2017 Jun; 97():228-234. PubMed ID: 28483241
[TBL] [Abstract][Full Text] [Related]
23. Generation of an induced pluripotent stem cell line (TRNDi003-A) from a Noonan syndrome with multiple lentigines (NSML) patient carrying a p.Q510P mutation in the PTPN11 gene.
Li R; Baskfield A; Lin Y; Beers J; Zou J; Liu C; Jaffré F; Roberts AE; Ottinger EA; Kontaridis MI; Zheng W
Stem Cell Res; 2019 Jan; 34():101374. PubMed ID: 30640061
[TBL] [Abstract][Full Text] [Related]
24. Developmental SHP2 dysfunction underlies cardiac hypertrophy in Noonan syndrome with multiple lentigines.
Lauriol J; Cabrera JR; Roy A; Keith K; Hough SM; Damilano F; Wang B; Segarra GC; Flessa ME; Miller LE; Das S; Bronson R; Lee KH; Kontaridis MI
J Clin Invest; 2016 Aug; 126(8):2989-3005. PubMed ID: 27348588
[TBL] [Abstract][Full Text] [Related]
25. LEOPARD-type SHP2 mutant Gln510Glu attenuates cardiomyocyte differentiation and promotes cardiac hypertrophy via dysregulation of Akt/GSK-3β/β-catenin signaling.
Ishida H; Kogaki S; Narita J; Ichimori H; Nawa N; Okada Y; Takahashi K; Ozono K
Am J Physiol Heart Circ Physiol; 2011 Oct; 301(4):H1531-9. PubMed ID: 21803945
[TBL] [Abstract][Full Text] [Related]
26. Paraspinal neurofibromas and hypertrophic neuropathy in Noonan syndrome with multiple lentigines.
Conboy E; Dhamija R; Wang M; Xie J; Dyck PJ; Bridges AG; Spinner RJ; Clayton AC; Watson RE; Messiaen L; Babovic-Vuksanovic D
J Med Genet; 2016 Feb; 53(2):123-6. PubMed ID: 26337637
[TBL] [Abstract][Full Text] [Related]
27. Natural History of Hypertrophic Cardiomyopathy in Noonan Syndrome With Multiple Lentigines.
Monda E; Prosnitz A; Aiello R; Lioncino M; Norrish G; Caiazza M; Drago F; Beattie M; Tartaglia M; Russo MG; Colan SD; Calcagni G; Gelb BD; Kaski JP; Roberts AE; Limongelli G
Circ Genom Precis Med; 2023 Aug; 16(4):350-358. PubMed ID: 37199218
[TBL] [Abstract][Full Text] [Related]
28. Co-occurrence of hypertrophic cardiomyopathy and myeloproliferative disorder in a neonate with Noonan syndrome carrying Thr73Ile mutation in PTPN11.
Yagasaki H; Nakane T; Hasebe Y; Watanabe A; Kise H; Toda T; Koizumi K; Hoshiai M; Sugita K
Am J Med Genet A; 2015 Dec; 167A(12):3144-7. PubMed ID: 26286251
[TBL] [Abstract][Full Text] [Related]
29. Hypertrophic cardiomyopathy in an adult patient with Noonan syndrome with multiple lentigines.
Rivero-García P; Campuzano-Estrada IDC; Hernandez-Felix JH
Clin Case Rep; 2023 Jun; 11(6):e7607. PubMed ID: 37361648
[TBL] [Abstract][Full Text] [Related]
30. PTPN11 gene mutation and severe neonatal hypertrophic cardiomyopathy: what is the link?
Faienza MF; Giordani L; Ferraris M; Bona G; Cavallo L
Pediatr Cardiol; 2009 Oct; 30(7):1012-5. PubMed ID: 19582499
[TBL] [Abstract][Full Text] [Related]
31. Natural history and outcomes in paediatric RASopathy-associated hypertrophic cardiomyopathy.
Boleti O; Norrish G; Field E; Dady K; Summers K; Nepali G; Bhole V; Uzun O; Wong A; Daubeney PEF; Stuart G; Fernandes P; McLeod K; Ilina M; Ali MNL; Bharucha T; Donne GD; Brown E; Linter K; Jones CB; Searle J; Regan W; Mathur S; Boyd N; Reinhardt Z; Duignan S; Prendiville T; Adwani S; Kaski JP
ESC Heart Fail; 2024 Apr; 11(2):923-936. PubMed ID: 38217456
[TBL] [Abstract][Full Text] [Related]
32. mTOR pathway in human cardiac hypertrophy caused by LEOPARD syndrome: a different role compared with animal models?
Cui H; Song L; Zhu C; Zhang C; Tang B; Wang S; Wu G; Zou Y; Huang X; Hui R; Wang S; Wang J
Orphanet J Rare Dis; 2019 Nov; 14(1):252. PubMed ID: 31722741
[TBL] [Abstract][Full Text] [Related]
33. Cardiovascular disease in Noonan syndrome.
Pierpont ME; Digilio MC
Curr Opin Pediatr; 2018 Oct; 30(5):601-608. PubMed ID: 30024444
[TBL] [Abstract][Full Text] [Related]
34. LEOPARD syndrome: a variant of Noonan syndrome strongly associated with hypertrophic cardiomyopathy.
Carcavilla A; Santomé JL; Pinto I; Sánchez-Pozo J; Guillén-Navarro E; Martín-Frías M; Lapunzina P; Ezquieta B
Rev Esp Cardiol (Engl Ed); 2013 May; 66(5):350-6. PubMed ID: 24775816
[TBL] [Abstract][Full Text] [Related]
35. Combined PTPN11 and MYBPC3 Gene Mutations in an Adult Patient with Noonan Syndrome and Hypertrophic Cardiomyopathy.
Caiazza M; Rubino M; Monda E; Passariello A; Fusco A; Cirillo A; Esposito A; Pierno A; De Fazio F; Pacileo R; Evangelista E; Pacileo G; Russo MG; Limongelli G
Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32824488
[TBL] [Abstract][Full Text] [Related]
36. Nonreentrant atrial tachycardia occurs independently of hypertrophic cardiomyopathy in RASopathy patients.
Levin MD; Saitta SC; Gripp KW; Wenger TL; Ganesh J; Kalish JM; Epstein MR; Smith R; Czosek RJ; Ware SM; Goldenberg P; Myers A; Chatfield KC; Gillespie MJ; Zackai EH; Lin AE
Am J Med Genet A; 2018 Aug; 176(8):1711-1722. PubMed ID: 30055033
[TBL] [Abstract][Full Text] [Related]
37. Noonan Syndrome Case Report: PTPN11 and Other Potential Genetic Factors Contributing to Lethal Hypertrophic Right Ventricular Cardiomyopathy.
Daoud E; Zwick D
Pediatr Dev Pathol; 2019; 22(4):386-390. PubMed ID: 30665336
[TBL] [Abstract][Full Text] [Related]
38. Identification of a PTPN11 hot spot mutation in a child with atypical LEOPARD syndrome.
Zhang J; Shen J; Cheng R; Ni C; Liang J; Li M; Yao Z
Mol Med Rep; 2016 Sep; 14(3):2639-43. PubMed ID: 27484170
[TBL] [Abstract][Full Text] [Related]
39. Hypertrophic cardiomyopathy in Noonan syndrome.
Nishikawa T; Ishiyama S; Shimojo T; Takeda K; Kasajima T; Momma K
Acta Paediatr Jpn; 1996 Feb; 38(1):91-8. PubMed ID: 8992870
[TBL] [Abstract][Full Text] [Related]
40. The Q510E mutation in Shp2 perturbs heart valve development by increasing cell migration.
Edwards MA; Crombie K; Schramm C; Krenz M
J Appl Physiol (1985); 2015 Jan; 118(1):124-31. PubMed ID: 25359717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
